Distribution of Study Phases

In the realm of clinical trials, the distribution of study phases plays a crucial role in advancing medical research. With a staggering 296,014 studies falling under an unspecified phase, the landscape is vast and varied. Among the specified phases, PHASE2 takes the lead with 19% of the total studies, followed by PHASE1 at 14% and PHASE3 at 13%. The data also reveals interesting combinations like PHASE1|PHASE2 and PHASE2|PHASE3, showcasing the complexity of modern research methodologies. However, it's worth noting the absence of data for certain phases, hinting at potential gaps in the current understanding of clinical trial progression.